Exelixis, INC Form 4 insider transactions

Director Jack L. Wyszomierski exercised stock options and sold shares of Exelixis, Inc. on February 28, 2025, according to a Form 4 filing with the SEC.

Christopher J. Senner, EVP and CFO of Exelixis, reports acquiring 59,648 shares of common stock through the vesting of restricted stock units (RSUs).

Patrick J. Haley, EVP, Commercial at Exelixis, Inc., sold 52,636 shares of common stock at an average price of $36.98 on February 24, 2025.

Director Bob Oliver exercised stock options and sold shares of Exelixis stock on February 25, 2025.

Dana Aftab, CSO/EVP of Discovery & Translational Research at Exelixis, sold 26,987 shares of common stock at $36.75 on February 24, 2025.

Exelixis CEO Michael Morrissey gifted 177,985 shares of common stock to the Morrissey Family Trust on February 24, 2025.

Christopher J. Senner, EVP and CFO of Exelixis, Inc., reports the acquisition and disposition of company stock through option exercise and open market sales.

Christopher J. Senner, EVP and CFO of Exelixis, reports the withholding of shares to cover taxes related to vesting restricted stock units and shares held in a 401(k) plan.

Director Mary C. Beckerle reports exercising stock options and selling shares of Exelixis, Inc. common stock.

Director George Poste exercised options and sold shares of Exelixis, Inc. on February 14, 2025.

Jeffrey Hessekiel, EVP & General Counsel of Exelixis, reports changes in beneficial ownership of company stock due to tax withholding and holdings in a 401(k) plan.

Patrick J. Haley, EVP, Commercial at Exelixis, Inc., reports the withholding of shares to cover taxes related to vesting restricted stock units and updates beneficial ownership.

Dana Aftab, CSO/EVP of Discovery & Translational Research at Exelixis, reports disposition of shares to cover tax obligations related to vesting restricted stock units.

Director Maria C. Freire reports exercising stock options and selling shares of Exelixis, Inc. common stock on February 14, 2025.

Michael Morrissey, CEO of Exelixis, reports the withholding of shares for tax obligations and beneficial ownership of common stock and restricted stock units.

Director Sue Gail Eckhardt reports exercising stock options and selling shares of Exelixis, Inc. common stock on February 14, 2025.

Exelixis CEO Michael Morrissey acquired 473,226 shares of common stock through performance-based vesting, while also disposing of shares to cover tax obligations.

Exelixis's CFO, Christopher J. Senner, acquired 132,973 shares of common stock due to the vesting of performance-based restricted stock units, while also disposing of shares to cover tax obligations.

Exelixis' EVP & General Counsel, Jeffrey Hessekiel, acquired 118,780 shares of common stock following the vesting of performance-based restricted stock units.

Exelixis CSO/EVP Dana Aftab acquired 104,106 shares of common stock and disposed of 22,570 shares to cover taxes following the vesting of performance-based restricted stock units.

Exelixis EVP, Commercial, Patrick J. Haley, acquired 123,750 shares of common stock due to the vesting of performance-based restricted stock units, while also disposing of shares to cover tax obligations.

Exelixis CEO Michael Morrissey gifted 179,788 shares of common stock to a family trust and reports holdings including restricted stock units and shares in a 401(k).

Exelixis' EVP & General Counsel, Jeffrey Hessekiel, executed multiple stock transactions including option exercises, sales, and a gift, resulting in a net decrease in his direct holdings.

Exelixis EVP, Commercial, Patrick J. Haley, sold 10,000 shares of common stock at $35.27 per share on November 22, 2024, under a pre-arranged 10b5-1 trading plan.

Exelixis's EVP and CFO, Christopher J. Senner, reported the withholding of 17,506 shares for tax obligations and holdings of 704,174 shares of common stock, including restricted stock units, and 2,723 shares held indirectly through a 401(k) plan.

Exelixis CEO Michael Morrissey sold 47,642 shares to cover taxes related to vested performance-based restricted stock units, while still holding a significant number of shares directly and indirectly.

Exelixis's EVP, Commercial, Patrick J. Haley, sold a total of 41,588 shares of common stock in multiple transactions, while also having shares withheld for tax obligations.

Exelixis' EVP & General Counsel, Jeffrey Hessekiel, reports the withholding of 14,672 shares for tax obligations and holdings of 515,653 shares, including those from restricted stock units and a 401(k) plan.

Exelixis CSO Dana Aftab reports the withholding of 12,838 shares for tax obligations and the holding of 486,107 shares directly and 5,835 shares indirectly through a 401(k) plan.

Exelixis EVP Amy C. Peterson sold 27,224 shares of common stock to cover taxes related to vesting restricted stock units.